Propeller Health said today that it inked a collaborative deal with Medical International Research to integrate MIR’s mobile and clinical spirometers into the Propeller system.
Spirometry, measuring lung function by how much air is inhaled and exhaled, can help provide a physiological measurement for disease progression in patients with asthma or chronic obstructive pulmonary disease. Regular assessment can enable patients and their healthcare providers to monitor the patient’s progress and evaluate how they respond to a particular treatment.
The Madison, Wis.-based company’s platform automatically collects data from connected devices so patients and physicians can monitor their status.
“We’re excited to partner with MIR to introduce their connected spirometers to participants in Propeller,” CEO David Van Sickle said in prepared remarks. “Periodic assessment can be helpful in monitoring whether treatment is truly controlling symptoms and improving quality of life. These next-generation, mobile spirometers make it possible for patients to better understand their lung function at home and in the community.”
“I am excited about this partnership with Propeller as it offers our customers a new option in the digital management of respiratory diseases making available a comprehensive range of sensors. It happens at the right time now that MIR has launched a new generation of truly ‘Smart’ spirometers, which provide the same accuracy of a clinical setting and connect wirelessly to the Propeller System,” MIR national sales & business development manager John Cello added.